Ticker > Company >

Procter&Gamble Healt share price

Procter & Gamble Health Ltd.

NSE: PGHL BSE: 500126 SECTOR: Pharmaceuticals & Drugs  107k   378   40

5840.00
+1.05 (0.02%)
BSE: 13 Jun 04:01 PM

Price Summary

Today's High

₹ 5892.95

Today's Low

₹ 5712

52 Week High

₹ 6107.55

52 Week Low

₹ 4905.65

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

9694.04 Cr.

Enterprise Value

9449.68 Cr.

No. of Shares

1.66 Cr.

P/E

38.59

P/B

18.05

Face Value

₹ 10

Div. Yield

4.45 %

Book Value (TTM)

₹  323.48

CASH

244.36 Cr.

DEBT

0 Cr.

Promoter Holding

51.82 %

EPS (TTM)

₹  151.32

Sales Growth

-6.37%

ROE

31.58 %

ROCE

42.52%

Profit Growth

-12.42 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Procter & Gamble Health Ltd.

Seven seas evion nasvision Polybion Livogen Neurobion

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-6.37%
3 Year4.5%
5 Year6.28%

Profit Growth

1 Year-12.42%
3 Year4.37%
5 Year-24.85%

ROE%

1 Year31.58%
3 Year31.64%
5 Year27.55%

ROCE %

1 Year42.52%
3 Year42.34%
5 Year37.02%

Debt/Equity

0

Price to Cash Flow

42.46

Interest Cover Ratio

380.6111

CFO/PAT (5 Yr. Avg.)

1.05940124306116

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 51.82 0.00
Dec 2024 51.82 0.00
Sep 2024 51.82 0.00
Jun 2024 51.82 0.00
Mar 2024 51.82 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 31.6447323186025% over the past 3 years.
  • Company has been maintaining healthy ROCE of 42.343934989648% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 380.6111.
  • The Company has been maintaining an effective average operating margins of 23.8088078746521% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -158.5615 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.05940124306116.
  • The company has a high promoter holding of 51.82%.

 Limitations

  • The company has shown a poor profit growth of 4.36547652430048% for the Past 3 years.
  • The company has shown a poor revenue growth of 4.50393286092057% for the Past 3 years.
  • The company is trading at a high PE of 38.59.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 252.48 283.88 313.41 309.77 310.99
Total Expenditure 185.04 235.63 199.37 186.34 230.07
Operating Profit 67.44 48.25 114.04 123.43 80.92
Other Income 2.27 2.13 3.28 3.96 3.11
Interest 0.15 0.2 0.15 0.15 0.13
Depreciation 6.84 7.16 5.77 5.55 5.37
Exceptional Items 0 -20.19 0 0 0
Profit Before Tax 62.72 22.83 111.4 121.69 78.53
Tax 16.16 6.05 29.07 30.79 17.35
Profit After Tax 46.56 16.78 82.33 90.9 61.18
Adjusted EPS (Rs) 28.05 10.11 49.6 54.76 36.86

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Jun 2020 Jun 2021 Jun 2022 Jun 2023 Jun 2024
Net Sales 1355.86 1008.73 1114.41 1229.62 1151.26
Total Expenditure 1041.52 762.71 846.73 904.94 845.26
Operating Profit 314.34 246.02 267.68 324.68 306
Other Income 69.96 18.1 13.19 18.39 15.63
Interest 0 0.8 0.42 0.77 0.72
Depreciation 29.45 30.04 27.08 28.1 27.4
Exceptional Items 0 0 0 0 -20.19
Profit Before Tax 354.85 233.28 253.37 314.2 273.32
Tax 100.77 56.48 60.85 84.73 72.34
Net Profit 254.08 176.8 192.52 229.47 200.98
Adjusted EPS (Rs.) 153.06 106.51 115.98 138.23 121.07

Balance Sheet (All Figures are in Crores.)

Particulars Jun 2020 Jun 2021 Jun 2022 Jun 2023 Jun 2024
Equity and Liabilities
Share Capital 16.6 16.6 16.6 16.6 16.6
Total Reserves 889.74 687.11 599.89 734.29 521.64
Borrowings 0 0 0 0 0
Other N/C liabilities 667.16 723.42 713.63 803 840.55
Current liabilities 538.62 550.68 607.73 679.08 625.3
Total Liabilities 2112.12 1977.81 1937.85 2232.97 2004.09
Assets
Net Block 97.92 100.96 109.06 141.72 126.6
Capital WIP 21.45 39.15 40.6 32.49 5.89
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 724.61 795.9 801.72 885.23 939.09
Other N/C Assets 3.3 2.95 2.6 2.25 1.9
Current Assets 1264.84 1038.85 983.87 1171.28 930.61
Total Assets 2112.12 1977.81 1937.85 2232.97 2004.09
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Jun 2020 Jun 2021 Jun 2022 Jun 2023 Jun 2024
Profit from operations 354.85 233.28 253.37 314.2 273.32
Adjustment -12.16 40.89 27.31 41.49 52.27
Changes in Assets & Liabilities -5.73 41.22 -47.3 -30.02 -12.12
Tax Paid -101.59 -68.13 -63.86 -89.66 -85.18
Operating Cash Flow 235.37 247.26 169.52 236.01 228.29
Investing Cash Flow 164.64 -32.27 -25.54 -21.5 -6.87
Financing Cash Flow -883.41 -386.63 -288.63 -98.47 -418.11
Net Cash Flow -483.4 -171.64 -144.65 116.04 -196.69

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 51.82 51.82 51.82 51.82 51.82
procter and gamble overse... 51.82 51.82 51.82 51.82 51.82
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 48.18 48.18 48.18 48.18 48.18
icici prudential smallcap... - - - 2.77 2.78
investor education and pr... 0.36 0.36 0.36 0.38 0.38
life insurance corporatio... 2.24 2.45 - 2.19 2.03
nippon life india trustee... 3.98 3.98 4.10 4.10 4.10
uti-mnc fund - - 1.89 1.89 1.90
icici prudential mnc fund... - - 2.61 - -
lici asm non par - - 2.49 - -
icici prudential s&p bse ... 2.10 2.60 - - -
uti - healthcare fund 1.64 1.87 - - -

Annual Reports

Title Action
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY ACTION
Credit ICRA
TYPE AGENCY ACTION
No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER ACTION
Currently we do not have any Concall related to this company.Report us
TYPE QUARTER ACTION
Presentation Q2FY20

Company News

Procter&Gamble Healt Stock Price Analysis and Quick Research Report. Is Procter&Gamble Healt an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Procter&Gamble Healt and its performance over the period of time. Procter&Gamble Healt stock price today is Rs 5831.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Procter&Gamble Healt cash from the operating activity was Rs 228.29 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Procter&Gamble Healt has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Procter&Gamble Healt , the EPS growth was -12.4155 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Procter&Gamble Healt has OPM of 26.5795736844848 % which is a good sign for profitability.
     
  • ROE: Procter&Gamble Healt have a healthy ROE of 31.5818 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Procter&Gamble Healt is Rs 5831. One can use valuation calculators of ticker to know if Procter&Gamble Healt share price is undervalued or overvalued.
Last Updated on:
Brief about Procter&Gamble Healt
X